Physician

Ailian Chen, MD

According to 2025 Medicare claims, Ailian Chen, MD (NPI: 1831298801) practices endocrinology in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Kings, NY. Chen uses personal NPI as billing NPI and primary practice location at 11364-9998.

Chen's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 85 traditional Medicare patients, billed 288 HCPCS/CPT codes, and received $31,070 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 1,193 prescription claims across 119 beneficiaries totaling $554,610 in drug costs, led by Farxiga (Dapagliflozin Propanediol). DME data shows 98 claims. Open Payments data shows 1 records totaling $77. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $246,194 to $31,070. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $534,362 and ending at $554,610. For DME billing, reported payments rose steadily, from $1,420 to $27,290.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	416	3,484	$246,194
2016	454	4,529	$321,969
2017	500	5,203	$350,371
2018	477	4,491	$312,921
2019	433	3,801	$265,248
2020	236	1,340	$88,361
2021	160	932	$80,289
2022	117	515	$52,088
2023	87	414	$42,794
2024	85	288	$31,070

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	257	2,848	$534,362
2016	266	3,050	$647,037
2017	281	3,123	$651,162
2018	303	3,468	$838,122
2019	292	2,986	$834,109
2020	220	2,031	$583,945
2021	166	1,172	$444,663
2022	150	1,029	$476,217
2023	117	1,108	$600,721
2024	119	1,193	$554,610

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	243	614	$7,330
2016	268	632	$8,282
2017	186	402	$4,466
2018	135	432	$4,802
2019	137	441	$8,499
2020	108	303	$3,211
2021	68	217	$5,335
2022	48	147	$8,670
2023	40	169	$26,585
2024	23	98	$27,018

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	20	20	$200
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	79	164	$114
76536	Ultrasound scan of head and neck soft tissue	53	63	$101
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	12	18	$82

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Farxiga	Dapagliflozin Propanediol	60	4,260	$78,981
Mounjaro	Tirzepatide	44	1,792	$62,868
Ozempic	Semaglutide	39	1,578	$51,868
Jardiance	Empagliflozin	42	2,460	$43,775
Trulicity	Dulaglutide	16	728	$23,995

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	12	62	$26,548
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	11	36	$470

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$77	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ailian Chen, MD?

Tedicare shows public-source Medicare data for Ailian Chen, MD (NPI 1831298801), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ailian Chen, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ailian Chen, MD?

A separate primary affiliated billing organization is not shown for this profile in the available data.

Does Ailian Chen, MD have Open Payments data?

Ailian Chen, MD has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.